Chinese patent medicine for treating cerebral infarction and preparation method thereof

Abstract

The invention discloses a Chinese patent medicine for treating cerebral infarction. The Chinese patent medicine is prepared from the following raw materials in parts by weight: 10-18 parts of corydalis tubers, 8-17 parts of airpotato yam rhizomes, 8-15 parts of curcuma longa, 10-15 parts of cowherb seeds, 6-12 parts of motherworts, 5-12 parts of dalbergia, 5-12 parts of loofah sponges, 2-8 parts of lucid ganoderma, 1-6 parts of polygala roots, 2-8 parts of fructus broussonetiae, 1-7 parts of yerbadetajo herbs, 2-10 parts of pseudobulbus cremastrae seu pleiones, 1-6 parts of girald oteroxygonum roots, 0.5-4 parts of oldenlandia diffusa, 1-8 parts of pond dragons, 2-6 parts of spina gleditsiae, 1.5-8 parts of eucommia ulmoides, 1-9 parts of sanchi, 1-6 parts of licorice roots and 1-6 parts of dwarf lilyturf tubers. The Chinese patent medicine is used for activating blood circulation, eliminating stasis, cooling blood and stopping blooding, so that the recovery from illness of lacunar infarction and cerebral embolism type cerebral infarction is promoted. According to clinical practice, a good curative effect is achieved.

Description

technical field [0001] The invention relates to a Chinese patent medicine for treating cerebral infarction and a preparation method thereof, belonging to the field of traditional Chinese medicine. Background technique [0002] Cerebral infarction (ischemic stroke) refers to ischemic necrosis or encephalomalacia of limited brain tissue caused by cerebral blood supply disturbance, ischemia and hypoxia. The common clinical types include cerebral thrombosis (arteriosclerotic cerebral Infarction), lacunar infarction and cerebral embolism, etc., cerebral infarction accounts for 80% of all strokes. Cerebral infarction has the characteristics of acute onset, critical condition, severe sequelae, high disability rate, and many complications, and is one of the diseases that seriously threaten human health. [0003] The recovery period within one year of the onset of cerebral infarction is the best secondary prevention period. During this period, most patients improve the fastest and h...

AI Technical Summary

Problems solved by technology

However, there is still a lack of Chinese patent medicine products that occupy the leading position in the treatment of stroke meridians in the recovery period in the market competition